3
Announcements
Trials
Browse
Landscape
Status
Completed
14
Recruiting
5
Terminated
3
Withdrawn
1
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
26
Thoracic
19
Breast
14
Other hematologic neoplasm
12
Genitourinary
12
Head & Neck
11
Gynecologic
9
Tumor-Agnostic
7
Lymphoid
7
Dermatologic
7
Myeloid
6
CNS
6
Sarcoma
5
Endocrine
3
Plasma cell
1
Other solid neoplasm
1
Conditions
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
Dexamethasone
69
Cyclophosphamide
43
Bortezomib
40
Lenalidomide
24
Melphalan
22
Thalidomide
19
pomalidomide
17
fludarabine
13
daratumumab
13
carfilzomib
10
Doxorubicin
8
Filgrastim
7
Busulfan
6
isatuximab
5
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Calcium Dobesilate
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
liposomal doxorubicin
3
ixazomib
3
dexamethasone acetate
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled